[Form 4] ZipRecruiter, Inc. Insider Trading Activity

Rhea-AI Filing Summary

FedEx Corporation (FDX) – Form 144 filing: An unidentified insider has filed a Notice of Proposed Sale covering 3,610 shares of FedEx common stock through Merrill Lynch. The intended trade date is 08 July 2025, and the shares have an estimated aggregate market value of $848,675, implying a per-share price near $235. The shares represent roughly 0.0015 % of FedEx’s 237.8 million shares outstanding, indicating the transaction is immaterial to the company’s share count and market capitalization. The shares were originally acquired on 28 September 2015 via stock-option exercise and will be sold for cash. No other insider sales by this individual have occurred in the last three months. Because Form 144 filings are intent-to-sell notices rather than completed trades, execution is not guaranteed. The filing contains no operational or financial updates on FedEx itself; therefore, market impact should be limited barring additional insider activity or larger-scale sales.

Positive

• None.

Negative

• Insider selling notice: Even though the amount is small, any insider liquidation can be interpreted by some investors as a potential negative signal.

Insights

Financial Analyst

TL;DR – Small insider intent-to-sell (0.0015 % of shares) is routine, with negligible financial impact.

This Form 144 discloses an insider’s plan to sell 3,610 FedEx shares (~$0.85 m). Relative to the company’s multibillion-dollar market cap, the sale is immaterial and unlikely to affect liquidity or valuation. The long holding period (acquired 2015) and absence of recent sales reduce concern about systematic divestment. Investors typically track cumulative insider trends; a single, modest notice does not alter the investment thesis. I view the filing as neutral with minimal market relevance.

Corporate Governance Expert

TL;DR – Routine Form 144; governance signal negligible unless followed by larger insider selling.

From a governance standpoint, the notice complies with Rule 144 disclosure for affiliates. The insider attests to no undisclosed adverse information and apparently follows orderly-trading practices (possible 10b5-1 plan). Transaction size is far below thresholds that generally raise red flags. Still, investors may wish to monitor subsequent filings to confirm this is an isolated sale rather than the start of a pattern. Overall governance impact: neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harrick Stephen J

(Last) (First) (Middle)

C/O INSTITUTIONAL VENTURE PARTNERS

3000 SAND HILL ROAD BLDG. 2, SUITE 250

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIPRECRUITER, INC. [ ZIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/03/2025		S		147,797	D	$5.27(1)	15,317	I	By Trust(2)
Class A Common Stock	07/07/2025		S		15,317	D	$5.29(3)	0	I	By Trust(2)
Class A Common Stock								3,809,348	I	By Institutional Venture Partners XIV L.P.(4)
Class A Common Stock								10,459	I	By Institutional Venture Management XIV, LLC(5)
Class A Common Stock								4,570,369	I	By Institutional Venture Partners XV, L.P.(6)
Class A Common Stock								24,294	I	By Institutional Venture Partners XV Executive Fund, L.P.(7)
Class A Common Stock								4,247	I	By Institutional Venture Management XV, LLC(8)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.22 to $5.31 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. The shares are held by a family trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.27 to $5.36 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The shares are held of record by Institutional Venture Partners XIV, L.P. ("IVP XIV"). Institutional Venture Management XIV LLC ("IVM XIV") is the general partner of IVP XIV. The Reporting Person is a managing director of IVM XIV and may be deemed to share voting and dispositive power over the shares held by IVP XIV. The Reporting Person disclaims beneficial ownership of the shares held by IVP XIV except to the extent of his pecuniary interest therein.

5. The shares are held of record by IVM XIV. The Reporting Person is a managing director of IVM XIV and may be deemed to share voting and dispositive power over the shares held by IVM XIV. The Reporting Person disclaims beneficial ownership of the shares held by IVM XIV except to the extent of his pecuniary interest therein.

6. The shares are held of record by IVP XV. Institutional Venture Management XV, LLC ("IVM XV") is the general partner of IVP XV. The Reporting Person is a managing director of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV. The Reporting Person disclaims beneficial ownership of the shares held by IVP XV except to the extent of his pecuniary interest therein.

7. The shares are held of record by IVP XV EF. IVM XV is the general partner of IVP XV EF. The Reporting Person is a managing director of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV EF. The Reporting Person disclaims beneficial ownership of the shares held by IVP XV except to the extent of his pecuniary interest therein.

8. The shares are held of record or beneficially by IVM XV. The Reporting Person is a managing director of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVM XV. The Reporting Person disclaims beneficial ownership of the shares held by IVM XV except to the extent of his pecuniary interest therein.

Remarks:

	Stephen J. Harrick, By /s/ Leslie Stolper, Attorney-in-Fact	07/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many FedEx (FDX) shares are being sold under this Form 144?

The filing covers 3,610 common shares of FedEx Corporation.

What is the approximate dollar value of the proposed FedEx insider sale?

The aggregate market value is $848,675 based on the filing data.

What percentage of FedEx’s outstanding shares does this sale represent?

About 0.0015 % of the company’s 237.8 million shares outstanding.

When is the insider planning to sell the FedEx shares?

The approximate sale date disclosed is 07 July 2025.

Where will the shares be sold and through which broker?

They are slated for sale on the NYSE via Merrill Lynch, 2100 Ross Ave, Dallas.

How were the shares originally acquired by the insider?

The insider exercised a stock option on 28 September 2015 to acquire the shares.